Cargando…
FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta−Analysis and Bioinformatics Analysis
BACKGROUND: Cancer is one of the leading causes of death worldwide. Early diagnosis can significantly lower cancer-related mortality. Studies have shown that the lncRNA Forkhead box P4 antisense RNA 1 (FOXP4-AS1) is aberrantly expressed in various solid tumors. A meta-analysis was performed to evalu...
Autores principales: | Zhang, Guangming, Wang, Yongfeng, Han, Xiaoyong, Lu, Tingting, Fu, Liangyin, Jin, Haojie, Yang, Kehu, Cai, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204280/ https://www.ncbi.nlm.nih.gov/pubmed/35719909 http://dx.doi.org/10.3389/fonc.2022.799265 |
Ejemplares similares
-
Clinicopathological Significance and Prognostic Values of Long Noncoding RNA BCYRN1 in Cancer Patients: A Meta-Analysis and Bioinformatics Analysis
por: Han, Xiaoyong, et al.
Publicado: (2022) -
Overexpression of LncRNA SNHG14 as a biomarker of clinicopathological and prognosis value in human cancers: A meta-analysis and bioinformatics analysis
por: Liu, Bin, et al.
Publicado: (2022) -
Clinicopathological and Prognostic Significance of Long Non-coding RNA MIAT in Human Cancers: A Review and Meta-Analysis
por: Wang, Yongfeng, et al.
Publicado: (2021) -
The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis
por: Fu, Liangyin, et al.
Publicado: (2022) -
Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis
por: Hu, Yanyan, et al.
Publicado: (2022)